Abeona Therapeutics (ABEO) Superinvestor holders
6 of the superinvestors we track hold Abeona Therapeutics (ABEO) in their latest 13F filings, $36M in total.
Summary
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $32M, 1.9% of the portfolio.
In their latest quarter: 2 opened a new position, 1 added, 3 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Wilmot Harkey Nantahala Capital Management |
Added | 5,136,490 | $32M | 1.9% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
New position | 360,800 | $2M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 194,827 | $1M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
New position | 80,737 | $498,955 | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 67,063 | $414,449 | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 57,100 | $352,878 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 6 |
| Q1 2026 | 6 |
| Q4 2025 | 5 |
| Q3 2025 | 5 |
| Q2 2025 | 4 |
| Q1 2025 | 3 |
| Q4 2024 | 3 |
| Q3 2024 | 3 |
Questions about Abeona Therapeutics
Which superinvestors own Abeona Therapeutics?
6 of the superinvestors we track hold Abeona Therapeutics (ABEO) in their latest 13F filings, $36M in total. Wilmot Harkey, Paul Tudor Jones, Paul Marshall, Two Sigma, Cliff Asness, David Shaw.
Who is the largest superinvestor holder of ABEO?
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $32M, 1.9% of the portfolio.
From Abeona Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.